94 results on '"Höfner, Thomas"'
Search Results
2. Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortality
3. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study
4. Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement
5. Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study
6. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected
7. Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
8. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
9. Variation across operating sites in urinary and sexual outcomes after radical prostatectomy in localized and locally advanced prostate cancer
10. Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study
11. Potential Candidates for Focal Therapy in Prostate Cancer in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Large Multicenter Cohort Study
12. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
13. Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic
14. Stage and Grade Migration in Prostate Cancer Treated With Radical Prostatectomy in a Large German Multicenter Cohort
15. Comparative assessment of docetaxel for safety and efficacy between hormone-sensitive and castration-resistant metastatic prostate cancer
16. Challenges and perspectives in use of artificial intelligence to support treatment recommendations in clinical oncology.
17. Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany
18. Nationwide analysis on the impact of socioeconomic land use factors and incidence of urothelial carcinoma
19. Efficacy of Targeted Treatment Beyond Third-Line Therapy in Metastatic Kidney Cancer: Retrospective Analysis From a Large-Volume Cancer Center
20. Defined Conditions for the Isolation and Expansion of Basal Prostate Progenitor Cells of Mouse and Human Origin
21. Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma—Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.
22. Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the Bladder
23. Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort
24. Lymph Node Density Affects Cancer-Specific Survival in Patients with Lymph Node–Positive Urothelial Bladder Cancer Following Radical Cystectomy
25. The impact of type 2 diabetes on the outcome of localized renal cell carcinoma
26. the Influence of Prostatic Anatomy and Neurotrophins on Basal Prostate Epithelial Progenitor Cells
27. Association Between the Number of Dissected Lymph Nodes During Pelvic Lymphadenectomy and Cancer-Specific Survival in Patients with Lymph Node–Negative Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
28. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy
29. Smartglass augmented reality‐assisted targeted prostate biopsy using cognitive point‐of‐care fusion technology.
30. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
31. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
32. Polysilsesquioxane derived ceramic foams with gradient porosity
33. Mg alloy infiltrated Si–O–C ceramic foams
34. A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer.
35. Robotic surgery can be safely performed for patients and healthcare workers during COVID‐19 pandemic.
36. Monoprophylaxis With Cephalosporins for Transrectal Prostate Biopsy After the Fluoroquinolone-Era: A Multi-Institutional Comparison of Severe Infectious Complications.
37. Acceptance, Indications and Chances of Focal Therapy in Localized Prostate Cancer: A Real-World Perspective of Urologists in Germany.
38. Antihormonelle Therapie des Prostatakarzinoms − Behandlungsindikation und kardiovaskuläres Risikoprofil − Vorteil für GnRH-Antagonisten?
39. Protein profile of basal prostate epithelial progenitor cells-stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo.
40. Pandemic Spread of COVID-19 Mutant Variants Will Facilitate Next-generation Sequencing Capacities for Personalised Medicine in Urologic Oncology.
41. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.
42. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder.
43. High–Normal Preoperative Potassium Level Is Associated with Reduced 30–Day Morbidity and Shorter Hospital Stay after Radical Cystectomy.
44. 923 CLINICAL AND PATHOLOGICAL NODAL STAGING SCORE FOR UROTHELIAL CARCINOMA OF THE BLADDER ARE VALID DECISION TOOLS FOR RISK ASSESSMENT AND CLINICAL DECISION-MAKING: AN EXTERNAL VALIDATION.
45. 1596 GENDER-SPECIFIC DIFFERENCES IN CARCINOMA-SPECIFIC SURVIVAL AFTER RADICAL CYSTECTOMY FOR PATIENTS WITH UROTHELIAL CARCINOMA OF THE URINARY BLADDER IN PATHOLOGICAL TUMOUR STAGE T4A.
46. 530 EXTERNAL VALIDATION OF DISEASE-FREE SURVIVAL AT 2 OR 3 YEARS AS A SURROGATE AND NEW PRIMARY ENDPOINT FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CANCER OF THE BLADDER.
47. 487 LYMPH NODE DENSITY AFFECTS CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE-POSITIVE UROTHELIAL BLADDER CANCER FOLLOWING RADICAL CYSTECTOMY.
48. 1176 OUTCOME PREDICTION IN PATIENTS WITH BLADDER CANCER AFTER RADICAL CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS.
49. 143 PATHOLOGICAL OUTCOMES OF PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER WHO COULD BE SCHEDULED FOR ACTIVE SURVEILLANCE OR HEMIABLATIVE THERAPY.
50. 138 PRECISE IDENTIFICATION OF PROSTATE CANCER (PCA) PATIENTS WHO COULD BE TREATED WITH FOCAL THERAPY USING CURRENT STANDARD TOOLS IN INITIAL PCA DIAGNOSIS IS NOT POSSIBLE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.